Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

13 Oct 2016 10:54

RNS Number : 4689M
Renishaw PLC
13 October 2016
 

Renishaw plc

Trading update

13th October 2016

 

Ahead of the AGM being held at noon today, we are providing a short trading update as follows:

 

Renishaw plc, the global high-precision metrology and healthcare manufacturer, publishes this trading update for the three months ended 30th September 2016. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

Revenue for the first quarter of the current financial year was £112.8m, compared with £98.2m for the corresponding period last year, with growth of 15%. There was growth in all regions, especially the Far East at 22% (9% at constant exchange rates) and Europe at 13% (3% at constant exchange rates).

 

By business sector, revenue in our metrology business increased by 16% to £108.8m compared with £93.7m last year, with underlying growth at constant exchange rates of 7%. Revenue in our healthcare business was £4.0m compared with £4.5m last year.

 

Profit before tax for the first quarter amounted to £14.1m (including a currency benefit of £3.7m) compared with £16.3m last year.

 

The Group's cost base reflects investments made in the previous year, including an increase in labour costs supporting global marketing expansion, further strategic investment in our research and development programmes and investment in skills for future growth. Across the Group, we continue to focus on our operating costs. Exchange rate movements have given rise to higher overseas operating costs in Sterling terms.

 

Renishaw Diagnostics Limited ("RDL")

Following an extensive review of the business, the Board has decided to discontinue operations at RDL, resulting in the 33 staff directly employed by RDL now being on notice of redundancy. Significant efforts have been made to find a collaboration or acquisition partner, however there have been no acceptable offers to date that could take RDL forward as a going concern. We continue to look at opportunities for the sale of RDL assets and to support employees in finding alternative employment. We would like to express our thanks to the employees of RDL for their considerable efforts since the company was formed in 2007.

The full carrying value of assets on the consolidated balance sheet which are at risk of impairment loss, along with estimated cessation costs, is expected to be in the region of £4.9m. The resultant costs, net of proceeds from asset disposals, will be reflected in the half year results. The operating costs of RDL in the 2016 financial year were £3.2m.

Financial position 

The Group balance sheet remains strong with net cash balances of £27.8m as at 30th September 2016 (30th June 2016: £21.3m), excluding the escrow account of £15.3m (30th June 2016: £15.3m) which provides additional security for the UK defined benefit pension scheme.

 

Outlook

The Board remains confident in the future prospects of the Group and, as stated in my statement in July 2016, we continue to anticipate growth in both revenue and profit in this financial year.

 

Sir David McMurtry

CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

13th October 2016

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEANEDFSDKFEF
Date   Source Headline
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration
26th Jul 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.